ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2

Oncogene

Volumn 23, Issue 57, 2004, Pages 9295-9302

  Jandrig, Burkhard ^a   Seitz, Susanne ^a   Hinzmann, Bernd ^b   Arnold, Wolfgang ^c   Micheel, Burkhard ^d   Koelble, Konrad ^e,f   Siebert, Reiner ^g   Schwartz, Arnfried ^a   Ruecker, Karin ^a   Schlag, Peter M ^f   Scherneck, Siegfried ^a   Rosenthal, André ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b Signature Diagnostics AG   (Germany)

^c Atugen AG   (Germany)

^d UNIVERSITY OF POTSDAM   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f Section of Pathology   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Breast cancer; Chromosome 8q11; ST18; Tumor suppressor genes

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHROMOSOME 8Q; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; ST18 GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 8; DNA METHYLATION; DNA PRIMERS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MICE; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 19944428666     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208131     Document Type: Article

References (26)

1. Adelaide J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Borresen-Dale AL, Lidereau R, Birnbaum D and Pebusque MJ. (1998). Genes Chromosomes Cancer, 22, 186-199.
2. Astrom A, D'Amore ES, Sainati L, Panarello C, Morerio C, Mark J and Stenman G. (2000). Int. J. Oncol., 16, 1107-1110.
3. Bardet V, Couque N, Cattolico L, Hetet G, Devaux I, Duprat S, Gressin L, Vilmer E, Cave H and Grandchamp B. (2002). Genes Chromosomes Cancer, 33, 178-187.
4. Bonfield JK, Smith KF and Staden R. (1995). Nucleic Acids Res., 23, 4992-4999.
5. Böttger V, Peters L-E and Micheel B. (1999). J. Mol. Recognit., 12, 191-197.
6. Burn TC, Connors TD, Klinger KW and Landes GM. (1995). Gene, 161, 183-187.
7. Chano T, Kontani K, Teramoto K, Okabe H and Ikegawa S. (2002). Nat. Genet., 31, 285-288.
8. Dahiya R, Perincher Y, Deng G and Lee C. (1998). Int. J. Oncol., 12, 811-816.
9. Esteller M. (2003). Adv. Exp. Med. Biol., 532, 39-49.
10. Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B and Melton DA. (2004). Development, 131, 165-179.
11. Haering CH and Nasmyth K. (2003). BioEssay, 25, 1178-1191.
12. Jallepalli PV and Lengauer C. (2001). Nat. Rev. Cancer, 1, 109-117.
13. Jandrig B, Grade K, Seitz S, Waindzoch B, Müller M, Bender E, Nothnagel A, Rohde K, Schlag PM, Kath R, Höffken K and Scherneck S. (1996). Int. J. Cancer, 68, 188-192.
14. Janke J, Schlüter K, Jandrig B, Theile M, Kölble K, Arnold W, Grinstein E, Schwartz A, Estevez-Schwarz L, Schlag PM, Jockusch BM and Scherneck S. (2000). J. Exp. Med., 191, 1675-1685.
15. Kim JG, Armstrong RC, v Agoston D, Robinsky A, Wiese C, Nagle J and Hudson LD. (1997). J. Neurosci. Res., 50, 272-290.
16. Lindner W and Robey FA. (1987). Int. J. Pept. Protein Res., 30, 794-800.
17. Nagase T, Ishikawa K, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O. (1998). DNA Res., 5, 31-39.
18. Osborne RJ and Hamshere MG. (2000). Cancer Res., 60, 3706-3712.
19. Seitz S, Rohde K, Nothnagel A, Pidde H, Ullrich O-M, El-Zehairy A, Haensch W, Jandrig B, Koelble K, Schlag PM and Scherneck S. (1997). Brit. J. Cancer, 76, 983-991.
20. Seitz S, Werner S, Fischer J, Nothnagel A, Schlag PM and Scherneck S. (2000). Eur. J. Cancer, 36, 1507-1513.
21. Ueki T, Walter KM, Skinner H, Jaffee E, Hruban RH and Goggins M. (2002). Oncogene, 21, 2114-2117.
22. Wang JC, Radford DM, Holt MS, Helms C, Goate A Brandt W, Parik M, Phillips NJ, DeSchryver K, Schuh ME, Fair KL, Ritter JH, Marshall P and Donis-Keller H. (1999). Genomics, 60, 1-11.
23. Widschwendter M and Jones PA. (2002). Oncogene, 21, 5462-5482.
24. Yang X, Yan L and Davidson NE. (2001). Endocr. Relat. Cancer, 8, 115-127.
25. Yee KS and Yu VC. (1998). J. Biol. Chem., 273, 5366-5374.
26. Zhang Y, Kreder D, Schwandner R, Krut O, Scherer G, Adam-Klages S, Siebert R, Kronke M and Schlegelberger B. (1999). Cytogenet. Cell Genet., 87, 115-116.